# Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. – FDA Inspection, Jul 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/istituto-biochimico-italiano-giovanni-lorenzini-spa/adea1d50-9113-462b-ae83-a62f7ff562da
Source feed: FDA_Inspections

> FDA inspection 1059331 of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A., July 17, 2018. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059331
- Company Name: Istituto Biochimico Italiano Giovanni Lorenzini S.p.A.
- Inspection Date: 2018-07-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1254712 - 2024-11-21](https://www.keypedia.com/records/fda_inspections/istituto-biochimico-italiano-giovanni-lorenzini-spa/1e8711dc-f739-44bb-8418-da1acbab80b2)
- FDA Inspection 1235389 - 2023-09-19
- FDA Inspection 1148007 - 2020-02-21
- [FDA Inspection 1017293 - 2017-07-04](https://www.keypedia.com/records/fda_inspections/istituto-biochimico-italiano-giovanni-lorenzini-spa/2cd85edd-4e1c-4ec3-9aaf-1e421ec77efc)
- [FDA Inspection 919376 - 2015-03-03](https://www.keypedia.com/records/fda_inspections/istituto-biochimico-italiano-giovanni-lorenzini-spa/10cd71ec-b40c-4c07-8651-596fd781a5be)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)
- [Company Rep](https://www.keypedia.com/people/xiaoping-guan/191018c9-9f60-4db0-a9eb-48314b53e515)

Company: https://www.keypedia.com/companies/istituto-biochimico-italiano-giovanni-lorenzini-spa/15ae51d8-a4ba-42a6-9100-2d04641f2514

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
